NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

UltraTech Cement Reports Strong Q4 FY26 Performance, Announces Record Dividend Payout

Shares of UltraTech Cement Ltd were largely flat in early trade on Tuesday after the company reported a strong Q4 FY26 financial performance and announced a record dividend payout. The stock was trading at Rs 12,000, down 0.08 percent, after ending Monday's session marginally higher at Rs 12,010.

UltraTech Cement reported a 21.2 percent year-on-year rise in net profit to Rs 3,000 crore for the January-March quarter, beating the CNBC-TV18 poll estimate of Rs 2,749 crore. EBITDA grew 21.3 percent to Rs 5,600.5 crore, also ahead of expectations. Margins expanded by 170 basis points to 21.7 percent. Revenue rose 12 percent on-year to Rs 25,799.5 crore, largely in line with estimates.

Financial MetricQ4 FY26Q4 FY25Year-over-Year Change
Net ProfitRs 3,000 croreRs 2,482 crore21.2%
EBITDARs 5,600.5 croreRs 4,630.5 crore21.3%
RevenueRs 25,799.5 croreRs 23,030.5 crore12%
EBITDA Margin21.7%20.5%170 basis points

Read also: Treasury Yields Experience Largest Increase in Two Weeks Following Release of Labor Market Data

Volume growth remained strong, with India sales volumes at 42.41 million tonnes, up 9.3 percent on-year, while domestic grey cement volumes (excluding India Cements) rose 15 percent to 42.01 million tonnes. The company also announced a special dividend of Rs 240 per share, its highest-ever payout, subject to shareholder approval.

Brokerages remained bullish on the stock despite flagging near-term challenges. Jefferies has a buy rating on UltraTech shares with a target price of Rs 14,050. It highlighted that the company ended FY26 on a strong note with robust EBITDA and volume growth, along with a record dividend payout. However, the brokerage cautioned that FY27 could be a tougher year due to cost headwinds, although pricing actions and cost savings may support EBITDA per tonne growth.

HSBC also maintained a buy call with a target price of Rs 14,200. It cited a beat on both EBITDA and profit driven by strong volumes and lower costs. The brokerage views the special dividend as a positive, and expects capital expenditure intensity to decline over FY27-29. It raised its EBITDA estimates for FY28-29.

UltraTech Cement also reiterated its growth plans, with capital commitments of over Rs 16,000 crore over the next three years, which are expected to take its consolidated capacity beyond 240 MTPA from over 200 MTPA currently. The company added that its cables and wires business is progressing as planned and is likely to be commissioned by the third quarter of FY27.

Read also: US-Iran Tensions Spark Uptick in Oil Prices Amid Global Market Decline

On a one-year basis, the UltraTech Cement stock is down 1.3 percent, compared with a 1 percent decline in the benchmark Nifty 50.

Investor Takeaway

Investors should consider UltraTech Cement's strong Q4 earnings and special dividend consideration for potential long-term growth.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.